Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Translation in Brief

Dysfunction junction

Shutting down a paracrine loop that promotes brain metastases

June 16, 2016 7:00 AM UTC

Researchers from Memorial Sloan Kettering Cancer Center have shown brain metastases build gap junctions to flood neighboring astrocytes with pro-inflammatory signaling molecules, causing the cells to secrete cytokines that fuel tumor growth via a paracrine feedback loop. The team has launched a pilot clinical study to see whether a gap junction inhibitor can kill the cycle and stem cancer growth in patients with recurrent brain metastases.

"We can potentially target host microenvironmental interactions specifically in the brain, which as far as I know has never been seen before," said Adrienne Boire, a neuro-oncologist at MSKCC and a neurology fellow in the lab of Joan Massagué. Boire co-authored the preclinical study, published in Nature last month, and is leading the Phase 0 trial...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article